Company · founded 2005
CoDa Therapeutics (United States)
San Diego, United States · codathx.com/about.html
- Citations, last 5 years
- 12
- Works, last 5 years
- 6
- h-index
- 12
- Scientists listed
- 0
- Grants since 2016
- 10
Grants received
2025–2028 · grant · PRMRP
Advancing a Novel, Orally Available Ferroptosis Inducer for the Treatment of VHL Disease
Mei Yee Koh · CoDa Therapeutics (United States) · funded by Congressionally Directed Medical Research Programs
2024–2027 · grant · OCRP
Ferroptosis as a Therapeutic Strategy for Clear Cell Ovarian Cancer
Mei Yee Koh · CoDa Therapeutics (United States) · funded by Congressionally Directed Medical Research Programs
2020–2023 · grant · KCRP
The Investigation of Ferroptosis as a Novel Therapeutic Paradigm for Kidney Cancer
Mei Yee Koh · CoDa Therapeutics (United States) · funded by Congressionally Directed Medical Research Programs
2018–2020 · research · R43
Development of a novel class of selective HIF-2A inhibitors for kidney cancer
Xiaohui Liu · CoDa Therapeutics (United States) · funded by National Institutes of Health
2018–2024 · research · R44
Development of a novel dual HIF-α inhibitor and inducer of ferroptosis for kidney cancer
Robert Lippert · CoDa Therapeutics (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Development of a novel class of selective HIF-2A inhibitors for kidney cancer
Xiaohui Liu · CoDa Therapeutics (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Development of a novel class of selective HIF-2A inhibitors for kidney cancer
Xiaohui Liu · CoDa Therapeutics (United States) · funded by National Institutes of Health
2018–2025 · research · R44
Development of a novel dual HIF-α inhibitor and inducer of ferroptosis for kidney cancer
Robert Lippert · CoDa Therapeutics (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Selective HDAC3 Inhibitors as a Novel Therapy for Drug Addiction
Edward Holson · CoDa Therapeutics (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Small Molecule Selective HDAC3 Inhibitors as a Novel Therapy for PTSD
Edward Holson · CoDa Therapeutics (United States) · funded by National Institutes of Health